nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00185	0.00185	CbGpPWpGaD
Yohimbine—HTR1B—GPCR ligand binding—C3—age related macular degeneration	0.00185	0.00185	CbGpPWpGaD
Yohimbine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Yohimbine—ADRA2A—G alpha (i) signalling events—C3—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RPE65—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RPE65—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Yohimbine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Yohimbine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—RHO—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—ELOVL4—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Yohimbine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—SLC16A8—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—ABCA4—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—ABCA4—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Yohimbine—HTR2B—GPCR ligand binding—C3—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—RHO—age related macular degeneration	0.00173	0.00173	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Yohimbine—HTR1F—GPCR downstream signaling—C3—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Yohimbine—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Yohimbine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—RHO—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RPE65—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Yohimbine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Yohimbine—HTR1A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Yohimbine—DRD3—GPCR ligand binding—C3—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR ligand binding—C3—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Yohimbine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—ABCA4—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—TGFBR1—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—C3—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—RHO—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—RHO—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ABCA4—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Yohimbine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Yohimbine—HTR1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ABCA4—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR ligand binding—C3—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Yohimbine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Yohimbine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Yohimbine—HTR1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ABCA4—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Yohimbine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—SQSTM1—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Yohimbine—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Yohimbine—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Yohimbine—HTR2C—GPCR ligand binding—C3—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Yohimbine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Yohimbine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—CD36—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—RHO—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR ligand binding—C3—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Yohimbine—HTR2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR ligand binding—C3—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—CD36—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RHO—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Yohimbine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Yohimbine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Yohimbine—DRD3—GPCR ligand binding—CCL2—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RHO—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Yohimbine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Yohimbine—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Yohimbine—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Yohimbine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—CCL2—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Yohimbine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Yohimbine—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Yohimbine—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Yohimbine—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Yohimbine—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000994	0.000994	CbGpPWpGaD
Yohimbine—HTR2B—GPCR downstream signaling—C3—age related macular degeneration	0.000982	0.000982	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000974	0.000974	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.00097	0.00097	CbGpPWpGaD
Yohimbine—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000968	0.000968	CbGpPWpGaD
Yohimbine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000966	0.000966	CbGpPWpGaD
Yohimbine—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000953	0.000953	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.000949	0.000949	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.00093	0.00093	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000915	0.000915	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—C3—age related macular degeneration	0.000914	0.000914	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—C3—age related macular degeneration	0.000914	0.000914	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000902	0.000902	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—LIPC—age related macular degeneration	0.0009	0.0009	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—C3—age related macular degeneration	0.000896	0.000896	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.000892	0.000892	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000883	0.000883	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—CETP—age related macular degeneration	0.000868	0.000868	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000867	0.000867	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000863	0.000863	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000851	0.000851	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000851	0.000851	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—APOE—age related macular degeneration	0.000834	0.000834	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—C3—age related macular degeneration	0.00083	0.00083	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—C3—age related macular degeneration	0.00083	0.00083	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000829	0.000829	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.000825	0.000825	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—KDR—age related macular degeneration	0.000817	0.000817	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000772	0.000772	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000772	0.000772	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—C3—age related macular degeneration	0.000771	0.000771	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000768	0.000768	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000759	0.000759	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000758	0.000758	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000755	0.000755	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000749	0.000749	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000742	0.000742	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000738	0.000738	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000731	0.000731	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000723	0.000723	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000719	0.000719	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000718	0.000718	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000706	0.000706	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000705	0.000705	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—CCL2—age related macular degeneration	0.000701	0.000701	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—C3—age related macular degeneration	0.0007	0.0007	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000699	0.000699	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000698	0.000698	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000697	0.000697	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000689	0.000689	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000688	0.000688	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000672	0.000672	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000669	0.000669	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000656	0.000656	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000651	0.000651	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000651	0.000651	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.000649	0.000649	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000649	0.000649	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000641	0.000641	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00064	0.00064	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000635	0.000635	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000626	0.000626	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000625	0.000625	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—VEGFA—age related macular degeneration	0.000613	0.000613	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000608	0.000608	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.00059	0.00059	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000583	0.000583	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000573	0.000573	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000568	0.000568	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000566	0.000566	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000563	0.000563	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000561	0.000561	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000548	0.000548	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000539	0.000539	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.000533	0.000533	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000529	0.000529	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000527	0.000527	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000522	0.000522	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000522	0.000522	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—CD36—age related macular degeneration	0.000522	0.000522	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000512	0.000512	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000497	0.000497	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.00049	0.00049	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—C3—age related macular degeneration	0.00049	0.00049	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—C3—age related macular degeneration	0.00049	0.00049	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000489	0.000489	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000481	0.000481	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000476	0.000476	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—APOE—age related macular degeneration	0.00046	0.00046	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000459	0.000459	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—APOE—age related macular degeneration	0.000456	0.000456	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000456	0.000456	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—VEGFA—age related macular degeneration	0.00045	0.00045	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000448	0.000448	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—KDR—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000445	0.000445	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.000443	0.000443	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.000439	0.000439	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000427	0.000427	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000425	0.000425	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000424	0.000424	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—C3—age related macular degeneration	0.000413	0.000413	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.000412	0.000412	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.000412	0.000412	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.000407	0.000407	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000404	0.000404	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000398	0.000398	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000396	0.000396	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.00039	0.00039	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000388	0.000388	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—APOE—age related macular degeneration	0.000385	0.000385	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000384	0.000384	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CCL2—age related macular degeneration	0.000384	0.000384	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000379	0.000379	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—KDR—age related macular degeneration	0.000377	0.000377	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000375	0.000375	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000374	0.000374	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000371	0.000371	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000369	0.000369	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000349	0.000349	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000346	0.000346	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000344	0.000344	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000342	0.000342	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000337	0.000337	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000336	0.000336	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000334	0.000334	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000333	0.000333	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCL2—age related macular degeneration	0.000323	0.000323	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.000318	0.000318	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000311	0.000311	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000306	0.000306	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CETP—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000294	0.000294	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000289	0.000289	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000288	0.000288	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000282	0.000282	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000265	0.000265	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000263	0.000263	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.000246	0.000246	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000246	0.000246	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000244	0.000244	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000215	0.000215	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000214	0.000214	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000208	0.000208	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000204	0.000204	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000188	0.000188	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000185	0.000185	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000181	0.000181	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000169	0.000169	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000159	0.000159	CbGpPWpGaD
